Related Experiment Videos
Osteoarthritis in the aged. Epidemiological issues and optimal management
1Department of Rheumatology, St Thomas's Hospital, London, England.
Drugs & Aging
|May 1, 1995
Summary
Osteoarthritis (OA) is a common joint disease, especially in older adults. Current treatments manage symptoms, focusing on risk factor modification, physiotherapy, and paracetamol (acetaminophen) as a first-line pain reliever.
Area of Science:
- Rheumatology
- Geriatrics
- Public Health
Background:
- Osteoarthritis (OA) is the most prevalent arthropathy, significantly increasing with age.
- Radiological evidence of OA affects a substantial portion of individuals aged 65 and older.
- The aging global population portends a growing healthcare burden from OA.
Purpose of the Study:
- To review the current landscape of osteoarthritis treatment.
- To evaluate the efficacy and justification of common therapeutic interventions for OA.
- To provide guidance on optimal pain management strategies for OA patients.
Main Methods:
- Literature review of current OA treatment guidelines and evidence.
- Analysis of symptomatic treatment approaches for osteoarthritis.
- Evaluation of pharmacological and non-pharmacological interventions.
Main Results:
- Current OA treatments are primarily symptomatic, lacking disease-modifying evidence.
- Optimal management combines risk factor modification (e.g., obesity) and non-pharmacological therapies (e.g., physiotherapy).
- Paracetamol (acetaminophen) is recommended as first-line analgesia; long-term NSAID use lacks strong justification and carries toxicity risks, especially in the elderly.
Conclusions:
- Osteoarthritis management requires a multifaceted approach focusing on symptom relief and risk reduction.
- Paracetamol is the preferred initial analgesic for OA.
- Cautious and reviewed use of NSAIDs is advised due to potential toxicity, particularly in older patients.